$TVRD

$0.87 +$0.02 (2.76%) Close

$TVRD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 13.3M shares outstanding

Who owns TVRD?

By type of holder

Institutions 16.5% Insiders 13.0% Everyone else 70.6%

Concentration Top 10 holders own 26.0%

Wirk Shaheen 6.6% · Slate Path Capital LP 5.3%

Institutional ownership

16.5%

-3.8 pts vs last qtr

Institutional holders

-11 vs last qtr

Net shares bought

−509.4K

by institutions in Q2 2026

New / sold out

11 / 22

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

UBS Group AG +60.7K
Russell Investments Group, Ltd. +19.9K

Biggest sellers in Q2 2026

BlackRock, Inc. −292.6K
Geode Capital Management, LLC −92.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Tvardi Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+202.3%

+202.35% a year

Each share's claim on the business

−66.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.72M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years37% 3–5 years4% 1–3 years36% Under 1 year22%

Quarterly turnover

16.3%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting TVRD on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SP Slate Path Capital LP	704.1K	5.28%	Unchanged	2025	0.0%
Shares held by quarter Peak holding704.1K (Q2'25) Change over 8 quarters+704.1K Share of the company5.280% Slate Path Capital LP's full portfolio →
B BlackRock, Inc.	95.5K	0.72%	−292.6K (−75.4%)	≤2021	0.0%
Shares held by quarter Peak holding742.5K (Q3'24) Change over 8 quarters−647.0K Share of the company0.720% BlackRock, Inc.'s full portfolio →

Slate Path Capital LP

704.1K

% of company

5.28%

Change vs last qtr

Unchanged

Held since

2025

BlackRock, Inc.

95.5K

% of company

0.72%

Change vs last qtr

−292.6K (−75.4%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Tvardi Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TVRD on Form N-PORT; together they hold 4.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$491K	258.4K	1.94%	0.00%	June 30, 2026
FS Fidelity Small Cap Index Fund Fidelity Salem Street Trust	$186K	59.0K	0.44%	0.00%	April 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$491K

% of company

1.94%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Small Cap Index Fund

Fidelity Salem Street Trust

Position value

$186K

% of company

0.44%

% of the fund

0.00%

As of

April 30, 2026

23 more funds behind a free account

See every fund holding Tvardi Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
WS Wirk Shaheen Insider	878.4K	6.59%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company6.590% Wirk Shaheen's insider activity →
HW Hall Wallace L JR Insider	493.5K	3.70%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.700% Hall Wallace L JR's insider activity →

Wirk Shaheen

Insider

878.4K

% of company

6.59%

Change vs last qtr

—

Held since

—

Hall Wallace L JR

Insider

493.5K

% of company

3.70%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Tvardi Therapeutics, Inc..

Comments